Date posted: 1 December 2020

NovaBiotics are pleased to announce that we will be participating in the 42nd European Cystic Fibrosis Conference (ECFS); 5-8 June 2019, Liverpool.

Our team will be presenting exciting new data on the antimicrobial mechanism of action, mucolytic mechanism of action and recent clinical data for our oral and inhaled CF drug candidates, Lynovex.

https://www.ecfs.eu/liverpool2…

Archives

2020 

2019